S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia

Summary The present guidelines are aimed at residents and board‐certified specialists in the fields of dermatology, ophthalmology, ENT, pediatrics, neurology, virology, infectious diseases, anesthesiology, general medicine and any other medical specialties involved in the management of patients with...

Full description

Saved in:
Bibliographic Details
Published inJournal der Deutschen Dermatologischen Gesellschaft Vol. 18; no. 1; pp. 55 - 78
Main Authors Gross, Gerd E., Eisert, Lisa, Doerr, Hans Wilhelm, Fickenscher, Helmut, Knuf, Markus, Maier, Philip, Maschke, Matthias, Müller, Rainer, Pleyer, Uwe, Schäfer, Michael, Sunderkötter, Cord, Werner, Ricardo N., Wutzler, Peter, Nast, Alexander
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.01.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary The present guidelines are aimed at residents and board‐certified specialists in the fields of dermatology, ophthalmology, ENT, pediatrics, neurology, virology, infectious diseases, anesthesiology, general medicine and any other medical specialties involved in the management of patients with herpes zoster. They are also intended as a guide for policymakers and health insurance funds. The guidelines were developed by dermatologists, virologists, ophthalmologists, ENT physicians, neurologists, pediatricians and anesthesiologists/pain specialists using a formal consensus process (S2k). Readers are provided with an overview of the clinical and molecular diagnostic workup, including antigen detection, antibody tests and viral culture. Special diagnostic situations and complicated disease courses are discussed. The authors address general and special aspects of antiviral therapy for herpes zoster and postherpetic neuralgia. Furthermore, the guidelines provide detailed information on pain management including a schematic overview, and they conclude with a discussion of topical treatment options.
Bibliography:The first two authors contributed equally to this publication.
05/24/2019
Valid until
05/2024
AWMF registry number: 013–023, 2019
Date of publication
ISSN:1610-0379
1610-0387
DOI:10.1111/ddg.14013